W. Mark Watson insider trades

Open-market stock purchases and sales by W. Mark Watson, Director at Vaxart, Inc, from SEC Form 4 filings since Sep 8, 2014.

Track record: 50% of 6 scored buys are up 5% or more since purchase, averaging +17%.

Recent trades

DateStockTradeValue
May 22, 2026VXRT Vaxart, IncBought$6.5K
Nov 17, 2025VXRT Vaxart, IncBought$6.2K
Nov 17, 2025VXRT Vaxart, IncBought$2K

Companies traded

  • VXRT Vaxart, Inc: 6 buys, last May 22, 2026
  • BDSI Biodelivery Sciences International Inc: 1 sale, last Mar 22, 2022
  • SYKE Sykes Enterprises Inc: 1 sale, last Aug 27, 2021
  • INTI Inhibitor Therapeutics, Inc: other filings, last Dec 22, 2020
  • HPPI HedgePath Pharmaceuticals, Inc: 1 buy, last Jun 3, 2019

Get free alerts when W. Mark Watson files a new trade →